We are live on
!
Find out more
LS
Leelyn Smith Portfolio holdings
AUM
$822M
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
+6.37%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$336M
AUM Growth
+$23.3M
(+7.4%)
Cap. Flow
+$15.2M
Cap. Flow
% of AUM
4.53%
Top 10 Holdings %
Top 10 Hldgs %
40.79%
Holding
397
New
32
Increased
145
Reduced
77
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.55M |
| 2 |
Merck
MRK
|
+$1.96M |
| 3 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
+$1.95M |
| 4 |
Alibaba
BABA
|
+$1.9M |
| 5 |
ARK Innovation ETF
ARKK
|
+$1.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$2.01M |
| 2 |
RTX Corp
RTX
|
+$1.65M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.17M |
| 4 |
First Trust Cloud Computing ETF
SKYY
|
+$863K |
| 5 |
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
|
+$830K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.61% |
| 2 | Healthcare | 7.68% |
| 3 | Consumer Discretionary | 7.22% |
| 4 | Financials | 5.18% |
| 5 | Consumer Staples | 5.01% |
Similar funds
SCM
SCP
GSWM
HVIA
MGAM
IA
WRPWM
RP
Leelyn Smith's Q1 2021 Portfolio in Review
As of Q1 2021, Leelyn Smith held 397 positions worth $336M, up 7.4% from $313M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Leelyn Smith deployed $15.2M of net new capital in Q1 2021, opening 32 new positions and adding to 145 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Charles Schwab, an estimated $2.01M trimmed.
- Leelyn Smith's largest Q1 2021 buy was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.
- Leelyn Smith added most to Invesco QQQ Trust in Q1 2021, an estimated $2.55M increase.
- Leelyn Smith's biggest Q1 2021 reduction was Charles Schwab, cutting an estimated $2.01M.
- Leelyn Smith fully exited Colgate-Palmolive in Q1 2021, selling an estimated $94K.
- Leelyn Smith's ten largest holdings make up 41% of its $336M portfolio in Q1 2021.
- Leelyn Smith opened 32 new positions and closed 9 in Q1 2021.
- Leelyn Smith's portfolio value rose 7.4% quarter-over-quarter to $336M.
Based on Leelyn Smith's 13F filing for Q1 2021, filed 5 May 2021.